Trial Profile
A Phase II/III trial of Gla-203 for Glaucoma
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 12 Dec 2016
Price :
$35
*
At a glance
- Drugs Gla 203 (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 12 Dec 2016 New trial record